Airain ltd - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 202 filers reported holding REPLIGEN CORP in Q2 2017. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Airain ltd ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2017$391,000
-13.7%
9,427
-35.8%
0.02%
-54.1%
Q4 2016$453,000
-42.3%
14,695
-49.8%
0.04%
-31.5%
Q1 2016$785,000
+66.0%
29,257
+72.3%
0.05%
+92.9%
Q3 2015$473,000
-54.5%
16,984
-50.4%
0.03%
-56.2%
Q1 2015$1,040,000
+402.4%
34,269
+229.1%
0.06%
+357.1%
Q3 2014$207,00010,4130.01%
Other shareholders
REPLIGEN CORP shareholders Q2 2017
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders